CRWV vs PFE: Which Is the Better Buy?
Side-by-side comparison of CoreWeave, Inc. Class A Common Stock and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
CoreWeave, Inc. Class A Common Stock · Technology
$86.76
+45.0% upside to fair value
Med Conviction
Grade B
VS
Pfizer Inc. · Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
CRWV has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWV |
PFE |
| Current Price |
$86.76 |
$27.64 |
| Fair Value Estimate |
$125.80 |
$30.94 |
| Upside to Fair Value |
+45.0%
|
+12.0%
|
| Market Cap |
$47.3B |
$157.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
36.3x
|
17.4x
|
| Price / Sales |
6.2x
|
2.5x
|
| Price / FCF |
—
|
14.3x
|
| Revenue Growth YoY |
+112.3%
|
+2.6%
|
| Gross Margin |
67.4%
|
71.3%
|
| Operating Margin |
-3.0%
|
25.1%
|
| Return on Equity |
-45.4%
|
4.9%
|
| Dividend Yield |
0% |
6.22% |
| FCF Yield |
—
|
6.97%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
CoreWeave operates a specialized GPU cloud platform purpose-built for generative AI workloads, offering high-performance GPU and CPU compute, storage, networking, and managed services to large enterprises from bare-metal and virtual server options. The business is growing explosively, with revenue up 112.3% year over year in the most recent quarter and a TTM gross margin of 67.4%, but it is doing…
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Accumulation Zones
| Metric |
CRWV |
PFE |
| Zone Low |
$94.35 |
$23.21 |
| Zone High |
$106.93 |
$26.30 |
| In Buy Zone? |
Yes
|
No
|